MORPHINE SULFATE au Canada
153 fiches de médicaments provenant de 22 titulaires portent ce nom dans les sources officielles. Collectées le 12 novembre 2026.
Médicaments, page 2
| Nom | Titulaire | Statut | Code |
|---|---|---|---|
| MORPHINE SULFATE INJECTION · SINGLE-USE AMPOULE · 15 MG per ML · SOLUTION | JUNO PHARMA CANADA INC. | authorised |
DIN
02561220Code de médicament DPD
106421
|
| MORPHINE SULFATE INJECTION USP · 100 MG per 100 ML · SOLUTION | STERINOVA INC. | authorised |
DIN
02491931Code de médicament DPD
98194
|
| MORPHINE SULFATE INJECTION USP · 10 MG per ML · SOLUTION | PFIZER CANADA ULC | cancelled |
DIN
00850322Code de médicament DPD
12991
|
| MORPHINE SULFATE INJECTION USP · 15 MG per ML · SOLUTION | PFIZER CANADA ULC | cancelled |
DIN
00850330Code de médicament DPD
12992
|
| MORPHINE SULFATE INJECTION USP · 2 MG per ML · LIQUID | SANDOZ CANADA INCORPORATED | authorised |
DIN
02242484Code de médicament DPD
66221
|
| MORPHINE SULFATE INJECTION USP · 2 MG per ML · SOLUTION | PFIZER CANADA ULC | cancelled |
DIN
00850314Code de médicament DPD
12990
|
| MORPHINE SULFATE INJECTION USP · 50 MG per 50 ML · SOLUTION | STERINOVA INC. | authorised |
DIN
02491885Code de médicament DPD
98189
|
| MORPHINE SULFATE INJECTION, USP · PREFILLED SYRINGE · 10 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02488647Code de médicament DPD
97874
|
| MORPHINE SULFATE INJECTION, USP · PREFILLED SYRINGE · 2 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02488620Code de médicament DPD
97871
|
| MORPHINE SULFATE INJECTION, USP · PREFILLED SYRINGE · 4 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02488639Code de médicament DPD
97872
|
| MORPHINE SULFATE INJECTION USP · PRESERVATIVE-FREE, SINGLE-USE · 1 MG per ML · SOLUTION | ICU MEDICAL CANADA INC | cancelled |
DIN
00636908Code de médicament DPD
6871
|
| MORPHINE SULFATE INJECTION USP · PRESERVATIVE-FREE, SINGLE-USE · 5 MG per ML · SOLUTION | ICU MEDICAL CANADA INC | cancelled |
DIN
00649619Code de médicament DPD
7136
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 10 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02482746Code de médicament DPD
97315
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 2 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02482681Code de médicament DPD
97311
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 4 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | cancelled |
DIN
02482703Code de médicament DPD
97312
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 5 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | cancelled |
DIN
02482711Code de médicament DPD
97313
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 8 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | cancelled |
DIN
02482738Code de médicament DPD
97314
|
| MORPHINE SULPHATE INJ 1MG/ML BP · 1 MG per ML · LIQUID | DAVID BULL LABORATORIES (CANADA) INC. | cancelled |
DIN
00885509Code de médicament DPD
14472
|
| MORPHINE SULPHATE INJECTION 1MG/ML · 1 MG per ML · LIQUID | HOSPIRA HEALTHCARE ULC | cancelled |
DIN
02137232Code de médicament DPD
31285
|
| MORPHINE SULPHATE INJECTION 2MG/ML · 2 MG per ML · LIQUID | HOSPIRA HEALTHCARE ULC | cancelled |
DIN
02137240Code de médicament DPD
31286
|
| MORPHINE SULPHATE INJECTION 50MG/ML · 50 MG per ML · LIQUID | HOSPIRA HEALTHCARE ULC | cancelled |
DIN
02137267Code de médicament DPD
31288
|
| MORPHINE SULPHATE INJECTION B.P. 25MG/ML · 25 MG per ML · LIQUID | DAVID BULL LABORATORIES (CANADA) INC. | cancelled |
DIN
02022672Code de médicament DPD
15941
|
| MORPHINE SULPHATE INJECTION BP 2MG/ML · 2 MG per ML · LIQUID | DAVID BULL LABORATORIES (CANADA) INC. | cancelled |
DIN
02003759Code de médicament DPD
14524
|
| MORPHINE SULPHATE INJECTION B.P. 50MG/ML · 50 MG per ML · LIQUID | DAVID BULL LABORATORIES (CANADA) INC. | cancelled |
DIN
02022680Code de médicament DPD
17139
|
| MORPHINE SULPHATE INJECTION, USP · 25 MG per ML · LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | cancelled |
DIN
02010380Code de médicament DPD
13913
|
| MORPHINE SULPHATE INJECTION,USP LIQ 1.1MG/ML · 1.1 MG per ML · LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | cancelled |
DIN
02010364Code de médicament DPD
14099
|
| MORPHINE SULPHATE INJECTION, USP LIQ50MG/ML · 50 MG per ML · LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | cancelled |
DIN
02009897Code de médicament DPD
13905
|
| M.O.S. SULPHATE 10MG TAB · 10 MG · TABLET | VALEANT CANADA LP / VALEANT CANADA S.E.C. | cancelled |
DIN
02009765Code de médicament DPD
14110
|
| M.O.S. SULPHATE 25MG TAB · 25 MG · TABLET | VALEANT CANADA LP / VALEANT CANADA S.E.C. | cancelled |
DIN
02009749Code de médicament DPD
14107
|
| M.O.S. SULPHATE 50MG TAB · 50 MG · TABLET | VALEANT CANADA LP / VALEANT CANADA S.E.C. | cancelled |
DIN
02009706Code de médicament DPD
14108
|
| M.O.S. SULPHATE 5MG TAB · 5 MG · TABLET | VALEANT CANADA LP / VALEANT CANADA S.E.C. | cancelled |
DIN
02009773Code de médicament DPD
14111
|
| MS CONTIN · 100 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014319Code de médicament DPD
14178
|
| MS CONTIN · 15 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02015439Code de médicament DPD
14395
|
| MS CONTIN · 200 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014327Code de médicament DPD
14142
|
| MS CONTIN · 30 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014297Code de médicament DPD
14176
|
| MS CONTIN · 60 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014300Code de médicament DPD
14394
|
| MS CONTIN SUPPOSITORIES - 100MG · 100 MG per SUP · SUPPOSITORY (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02145952Code de médicament DPD
18562
|
| MS CONTIN SUPPOSITORIES - 200MG · 200 MG per SUP · SUPPOSITORY (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02145960Code de médicament DPD
18561
|
| MS CONTIN SUPPOSITORIES - 30MG · 30 MG per SUP · SUPPOSITORY (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02146827Code de médicament DPD
18557
|
| MS CONTIN SUPPOSITORIES - 60MG · 60 MG per SUP · SUPPOSITORY (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02145944Code de médicament DPD
18563
|
| MS CONTIN TABLETS · 5 MG per TAB · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02229420Code de médicament DPD
47228
|
| MS CONTIN XL CAPSULES · 120 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242830Code de médicament DPD
66658
|
| MS CONTIN XL CAPSULES · 150 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242831Code de médicament DPD
66659
|
| MS CONTIN XL CAPSULES · 200 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242832Code de médicament DPD
66660
|
| MS CONTIN XL CAPSULES · 30 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242827Code de médicament DPD
66655
|
| MS CONTIN XL CAPSULES · 60 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242828Code de médicament DPD
66656
|
| MS CONTIN XL CAPSULES · 90 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242829Code de médicament DPD
66657
|
| MS.IR · 10 MG · TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014211Code de médicament DPD
14144
|
| MS.IR · 20 MG · TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014238Code de médicament DPD
16480
|
| MS.IR · 30 MG · TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014254Code de médicament DPD
16481
|
Besoin de cette liste dans votre propre système ?
Chaque fiche de cette page est disponible via l’API, avec sa source, sa licence et sa date de collecte.